England Launches GP Trial for Early Cancer Test

Doctors across England have initiated a major trial in primary care aiming to detect cancer at earlier stages through a new blood test. Under the STRIDE-RCT study, the National Health Service is collaborating with at least 200 general practice surgeries and involving more than 20,000 patients. The trial is designed to determine whether incorporating a simple blood test into standard care can help doctors identify hard-to-diagnose abdominal cancers, including pancreatic, stomach, liver, ovarian, and bowel cancers, which together affect around 71,000 people in England each year. The study will compare outcomes between two groups of GP practices: one using the blood test alongside standard diagnostic procedures and the other continuing with standard care alone. Although the potential impact is significant, no definitive results or conclusions from the trial are available at this stage. The initiative underscores ongoing efforts to catch cancers earlier and improve patient outcomes, especially in light of the challenges posed by rapidly progressing forms of the disease.